AHCO has 36-month beta value of 1.04. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AHCO is 70.47M, and currently, short sellers hold a 11.65% ratio of that float. The average trading volume of AHCO on April 11, 2024 was 1.14M shares.
AHCO) stock’s latest price update
AdaptHealth Corp (NASDAQ: AHCO)’s stock price has plunge by -4.90relation to previous closing price of 10.40. Nevertheless, the company has seen a -9.52% plunge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-08 that Investors with an interest in Medical – Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
AHCO’s Market Performance
AdaptHealth Corp (AHCO) has experienced a -9.52% fall in stock performance for the past week, with a -8.76% drop in the past month, and a 45.01% rise in the past quarter. The volatility ratio for the week is 4.83%, and the volatility levels for the past 30 days are at 4.41% for AHCO. The simple moving average for the last 20 days is -8.09% for AHCO stock, with a simple moving average of 3.53% for the last 200 days.
Analysts’ Opinion of AHCO
Many brokerage firms have already submitted their reports for AHCO stocks, with Jefferies repeating the rating for AHCO by listing it as a “Hold.” The predicted price for AHCO in the upcoming period, according to Jefferies is $8 based on the research report published on January 08, 2024 of the current year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see AHCO reach a price target of $6.50, previously predicting the price at $9.50. The rating they have provided for AHCO stocks is “Underperform” according to the report published on November 08th, 2023.
Stifel gave a rating of “Hold” to AHCO, setting the target price at $11 in the report published on May 10th of the previous year.
AHCO Trading at 5.88% from the 50-Day Moving Average
After a stumble in the market that brought AHCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.65% of loss for the given period.
Volatility was left at 4.41%, however, over the last 30 days, the volatility rate increased by 4.83%, as shares sank -8.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +34.38% upper at present.
During the last 5 trading sessions, AHCO fell by -9.52%, which changed the moving average for the period of 200-days by +3.78% in comparison to the 20-day moving average, which settled at $10.71. In addition, AdaptHealth Corp saw 35.67% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AHCO starting from Flynn James E, who sale 114,906 shares at the price of $10.70 back on Mar 12 ’24. After this action, Flynn James E now owns 11,528,863 shares of AdaptHealth Corp, valued at $1,229,494 using the latest closing price.
Flynn James E, the 10% Owner of AdaptHealth Corp, sale 182,607 shares at $11.02 during a trade that took place back on Mar 11 ’24, which means that Flynn James E is holding 11,643,769 shares at $2,012,557 based on the most recent closing price.
Stock Fundamentals for AHCO
Current profitability levels for the company are sitting at:
- -0.09 for the present operating margin
- 0.15 for the gross margin
The net margin for AdaptHealth Corp stands at -0.21. The total capital return value is set at -0.07. Equity return is now at value -37.75, with -13.66 for asset returns.
Based on AdaptHealth Corp (AHCO), the company’s capital structure generated 0.6 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 1.5. The interest coverage ratio of the stock is -2.13.
Currently, EBITDA for the company is 661.04 million with net debt to EBITDA at 3.59. When we switch over and look at the enterprise to sales, we see a ratio of 1.11. The receivables turnover for the company is 8.23for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.21.
Conclusion
To put it simply, AdaptHealth Corp (AHCO) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
